Potency of veterinary rabies vaccines in The Netherlands: A case for continued vigilance.
Commercial rabies vaccines, used by veterinarians in the Netherlands, were collected for testing in the mouse potency test. Of the six vaccines tested, two were clearly below the minimal requirements for potency of 1.0 IU. Of these six vaccines the rabies virus glycoprotein (GP) and nucleoprotein (NP) contents were determined in an antigen competition ELISA. The GP content proved to correlate well with the potency found in the mouse potency test (r = 0.95, p < 0.01), whereas no such correlation was found for the NP content (r approximately 0, p > 0.05). After the manufacturers were told... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 1996 |
Schlagwörter: | 0 (Glycoproteins) / 0 (Nucleoproteins) / 0 (Rabies Vaccines) / Animal Diseases/epidemiology/immunology/*prevention & control / Animals / Chiroptera/virology / Comparative Study / Dogs / Enzyme-Linked Immunosorbent Assay/veterinary / Glycoproteins/analysis / Mice/immunology / Netherlands/epidemiology / Nucleoproteins/analysis / Rabies Vaccines/analysis/immunology/*standards / Rabies virus/immunology / Rabies/epidemiology/prevention & control/*veterinary |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29199238 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://repub.eur.nl/pub/3580 |